{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:17:03Z","timestamp":1788545823875,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"American Cancer Society Institutional Research Grant awarded to the Hollings Cancer Center, Medical University of South Carolina"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s12094-020-02341-7","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T15:04:17Z","timestamp":1586185457000},"page":"2017-2025","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-4760","authenticated-orcid":false,"given":"A.","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alshareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Martinez Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. B. F.","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. G.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0072-3500","authenticated-orcid":false,"given":"L. K.","family":"Infinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"W. A.","family":"Vandergrift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1585-4450","authenticated-orcid":false,"given":"S. M.","family":"Lindhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5481-004X","authenticated-orcid":false,"given":"A. K.","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3788-6314","authenticated-orcid":false,"given":"S. J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5860-8452","authenticated-orcid":false,"given":"D.","family":"Cachia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"issue":"3","key":"2341_CR1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11060-010-0348-9","volume":"99","author":"S Hanft","year":"2010","unstructured":"Hanft S, Canoll P, Bruce JN. A review of malignant meningiomas: diagnosis, characteristics, and treatment. J Neurooncol. 2010;99(3):433\u201343.","journal-title":"J Neurooncol"},{"issue":"4","key":"2341_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3171\/jns.1992.77.4.0616","volume":"77","author":"H Maier","year":"1992","unstructured":"Maier H, Ofner D, Hittmair A, Kitz K, Budka H. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg. 1992;77(4):616\u201323.","journal-title":"J Neurosurg"},{"issue":"3","key":"2341_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","volume":"99","author":"C Mawrin","year":"2010","unstructured":"Mawrin C, Perry A. Pathological classification and molecular genetics of meningiomas. J Neurooncol. 2010;99(3):379\u201391.","journal-title":"J Neurooncol"},{"issue":"1","key":"2341_CR4","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1055\/s-0033-1359300","volume":"75","author":"J Gurberg","year":"2014","unstructured":"Gurberg J, Bouganim N, Shenouda G, Zeitouni A. A case of recurrent anaplastic meningioma of the skull base with radiologic response to hydroxyurea. J Neurol Surg Rep. 2014;75(1):e52\u2013e5555.","journal-title":"J Neurol Surg Rep"},{"issue":"5","key":"2341_CR5","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3171\/jns.2002.97.5.1078","volume":"97","author":"S Sadetzki","year":"2002","unstructured":"Sadetzki S, Flint-Richter P, Ben-Tal T, Nass D. Radiation-induced meningioma: a descriptive study of 253 cases. J Neurosurg. 2002;97(5):1078\u201382.","journal-title":"J Neurosurg"},{"issue":"6","key":"2341_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/02688690400022789","volume":"18","author":"SN Shenoy","year":"2004","unstructured":"Shenoy SN, Munish KG, Raja A. High dose radiation induced meningioma. Br J Neurosurg. 2004;18(6):617\u201321.","journal-title":"Br J Neurosurg"},{"issue":"1188","key":"2341_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainres.2007.10.074","volume":"10","author":"HH Al-Khalaf","year":"2008","unstructured":"Al-Khalaf HH, Lach B, Allam A, Hassounah M, Alkhani A, Elkum N, Alrokayan SA, Aboussekhra A. Expression of survivin and p16(INK4a)\/Cdk6\/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells. Brain Res. 2008;10(1188):25\u201334.","journal-title":"Brain Res"},{"issue":"5","key":"2341_CR8","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1186\/bcr2419","volume":"11","author":"RS Finn","year":"2009","unstructured":"Finn RS, Dering J, Conklin D, Kalous O, Cohen DJ, Desai AJ, Ginther C, Atefi M, Chen I, Fowst C, Los G, Slamon DJ. PD 0332991, a selective cyclin D kinase 4\/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res. 2009;11(5):R77.","journal-title":"Breast Cancer Res"},{"issue":"8","key":"2341_CR9","first-page":"2997","volume":"33","author":"JE Logan","year":"2013","unstructured":"Logan JE, Mostofizadeh N, Desai AJ, Von Euw E, Conklin D, Konkankit V, Hamidi H, Eckardt M, Anderson L, Chen HW, Ginther C, Taschereau E, Bui PH, Christensen JG, Belldegrun AS, Slamon DJ, Kabbinavar FF. PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4\/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity. Anticancer Res. 2013;33(8):2997\u20133004.","journal-title":"Anticancer Res"},{"issue":"5","key":"2341_CR10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/1078-0432.CCR-14-2258","volume":"21","author":"A DeMichele","year":"2015","unstructured":"DeMichele A, Clark AS, Tan KS, Heitjan DF, Gramlich K, Gallagher M, Lal P, Feldman M, Zhang P, Colameco C, Lewis D, Langer M, Goodman N, Domchek S, Gogineni K, Rosen M, Fox K, O'Dwyer P. CDK 4\/6 Inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment. Clin Cancer Res. 2015;21(5):995\u20131001.","journal-title":"Clin Cancer Res."},{"issue":"9","key":"2341_CR11","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.1007\/s13277-015-3388-0","volume":"36","author":"A Das","year":"2015","unstructured":"Das A, Miller R, Lee P, Holden CA, Lindhorst SM, Jaboin J, Vandergrift WA 3rd, Banik NL, Giglio P, Varma AK, Raizer JJ, Patel SJ. A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt\/\u03b2-catenin signaling pathway. Tumour Biol. 2015;36(9):7027\u201334.","journal-title":"Tumour Biol"},{"key":"2341_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-019-02240-6","author":"A Das","year":"2019","unstructured":"Das A, Alshareef M, Henderson F Jr, Martinez Santos JL, Vandergrift WA 3rd, Lindhorst SM, Varma AK, Infinger L, Patel SJ, Cachia D. Ganoderic acid A\/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth. Clin Transl Oncol. 2019. https:\/\/doi.org\/10.1007\/s12094-019-02240-6.","journal-title":"Clin Transl Oncol"},{"issue":"8","key":"2341_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4137\/CGM.S32801","volume":"1","author":"A Das","year":"2015","unstructured":"Das A, Cheng RR, Hilbert ML, Dixon-Moh YN, Decandio M, Vandergrift WA 3rd, Banik NL, Lindhorst SM, Cachia D, Varma AK, Patel SJ, Giglio P. Synergistic effects of crizotinib and temozolomide in experimental FIG-ROS1 fusion-positive glioblastoma. Cancer Growth Metastasis. 2015;1(8):51\u201360. https:\/\/doi.org\/10.4137\/CGM.S32801.","journal-title":"Cancer Growth Metastasis"},{"issue":"6","key":"2341_CR14","doi-asserted-by":"publisher","first-page":"7525","DOI":"10.1007\/s13277-015-4621-6","volume":"37","author":"A Das","year":"2016","unstructured":"Das A, McDonald DG, Dixon-Mah YN, Jacqmin DJ, Samant VN, Vandergrift WA 3rd, Lindhorst SM, Cachia D, Varma AK, Vanek KN, Banik NL, Jenrette JM 3rd, Raizer JJ, Giglio P, Patel SJ. RIP1 and RIP3 complex regulates radiation-induced programmed necrosis in glioblastoma. Tumour Biol. 2016;37(6):7525\u201334. https:\/\/doi.org\/10.1007\/s13277-015-4621-6(Epub 2015 Dec 18 PubMed PMID: 26684801).","journal-title":"Tumour Biol"},{"issue":"3","key":"2341_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11060-010-0331-5","volume":"99","author":"M Kalamarides","year":"2010","unstructured":"Kalamarides M, Peyre M, Giovannini M. Meningioma mouse models. J Neurooncol. 2010;99(3):325\u201331.","journal-title":"J Neurooncol"},{"issue":"2","key":"2341_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1750-3639.2007.00109.x","volume":"18","author":"GS Baia","year":"2008","unstructured":"Baia GS, Dinca EB, Ozawa T, Kimura ET, McDermott MW, James CD, VandenBerg SR, Lal A. An orthotopic skull base model of malignant meningioma. Brain Pathol. 2008;18(2):172\u20139.","journal-title":"Brain Pathol"},{"issue":"4","key":"2341_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1227\/01.NEU.0000255397.00410.8F","volume":"60","author":"TG Cargioli","year":"2007","unstructured":"Cargioli TG, Ugur HC, Ramakrishna N, Chan J, Black PM, Carroll RS. Establishment of an in vivo meningioma model with human telomerase reverse transcriptase. Neurosurgery. 2007;60(4):750\u20139.","journal-title":"Neurosurgery"},{"issue":"6","key":"2341_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00280-018-3684-7","volume":"82","author":"A Das","year":"2018","unstructured":"Das A, Henderson F Jr, Lowe S, Wallace GC 4th, Vandergrift WA 3rd, Lindhorst SM, Varma AK, Infinger LK, Giglio P, Banik NL, Patel SJ, Cachia D. Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma. Cancer Chemother Pharmacol. 2018;82(6):945\u201352. https:\/\/doi.org\/10.1007\/s00280-018-3684-7.","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02341-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-020-02341-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02341-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:12:56Z","timestamp":1617667976000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-020-02341-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["2341"],"URL":"https:\/\/doi.org\/10.1007\/s12094-020-02341-7","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]},"assertion":[{"value":"24 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Pfizer Inc. supplied palbociclib for this study. The results of this research and any intellectual property arising from this research are subject to existing rights and obligations to a third party, Pfizer Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Subjects gave their written, informed consent to participate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}